RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER-negative breast cancer modelsBabasaheb D. Yadav, Rhonda J. Rosengren|International Journal of Oncology|2012Cited by 26
A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell linesSébastien Taurin, Rhonda J. Rosengren|International Journal of Oncology|2015Cited by 13